Skip to main content

64th Western Intermountain Neurological Organization (WINO) Conference

64th WINO Conference

Save the Date

Friday, October 24, 2025

University Marriott Park Hotel

480 Wakara Way, Salt Lake City, UT 84108

Neurology 60th

In conjunction with WINO, we invite you to join us in celebrating the 60th Anniversary of the University of Utah Department of Neurology.  Please join us for a special dinner honoring this milestone at the Marriott University Park Hotel.  The meal is included in the registration fee.  All other guests will need to register for the dinner.

KEYNOTE SPEAKERS

Valerie Biousse

Valerie Biousse, MD
Emory School of Medicine

Valrie Biousse, MD, is a professor in the section of neuro-ophthalmology at Emory Eye Center and in the department of neurology, Emory University School of Medicine. She holds the Reunette Harris Chair of Ophthalmic Research and is the director of the Neuro-ophthalmology fellowship at Emory. Dr. Biousse is a fellow of the North American Neuro-Ophthalmology Society and of the French Society of Neurology and an elected member of the American Neurological Association and the American Ophthalmologic Association, and multiple other national and international societies, including the American Academies of Ophthalmology and Neurology and the French Society of Ophthalmology. Dr. Biousse regularly lectures throughout the world. Her current research focuses on four primary areas: Idiopathic intracranial hypertension, the use of non-mydriatic fundus photography for the diagnosis of neuro-ophthalmic disease in various clinical settings and the applications of artificial intelligence as a diagnostic aid, diagnostic errors and referral patterns in neuro-ophthalmology, and ocular manifestations of cerebrovascular diseases.

Nancy Newman

Nancy Newman, MD
Emory School of Medicine

Dr. Nancy J. Newman holds the LeoDelle Jolley Chair of Ophthalmology, and is Professor of Ophthalmology and Neurology and Instructor in Neurological Surgery at the Emory University School of Medicine, where she serves as the Director of Neuro-Ophthalmology.  She attended Princeton University, the University of London on a Marshall Scholarship, and Harvard Medical School.  She trained in Internal Medicine and Neurology at the Massachusetts General Hospital where she was Chief Resident in Neurology, and in Neuro-Ophthalmology at the Massachusetts Eye and Ear Infirmary.  She is a Fellow of the American Academy of Neurology, the American Neurological Association, and the North American Neuro-Ophthalmology Society.  She was President of the North American Neuro-Ophthalmology Society and is currently Senior Vice President for Education. She has served on the Editorial Boards of the American Journal of Ophthalmology, Seminars in Neurology, Journal of the Neurological Sciences and the Journal of Neuro-Ophthalmology.  She has over 600 publications, including scientific articles, book chapters and books, including the primary textbook in Neuro-Ophthalmology, Walsh & Hoyt’s Clinical Neuro-Ophthalmology, 5th and 6th Editions, and the popular manual Neuro-Ophthalmology Illustrated, 1st, 2nd and 3rd Editions.  She is a Trustee Emerita of Princeton University and was President of the Princeton Alumni Association.

 

Richard Lewis

Richard Lewis, MD
Cedars-Sinai Medical Center

Dr. Richard Lewis is Professor of Neurology at Cedars-Sinai Medical Center in Los Angeles where he had been Director of the EMG lab, the ALS clinic and MDA/CMT Clinics and Neuromuscular Program until he stepped down as he reduced his clinical activities in June 2024.  Dr. Lewis completed his neurology residency at the University of Pennsylvania School of Medicine where he remained as Assistant Professor. He transitioned to the University of Connecticut, where he played a pivotal role in establishing the Neuromuscular Program, Electromyography Lab, and an Adult Muscular Dystrophy Clinic focusing on Amyotrophic Lateral Sclerosis (ALS). Dr. Lewis then developed a group practice and was Clinical Assistant Professor of Neurology at Norfolk’s Eastern Virginia Medical School, where he directed a Muscular Dystrophy Association clinic.

He has been President of the Peripheral Nerve Society and was the Chair of the Inflammatory Neuropathy Special Interest Group (SIG). He is a co-author of both the 2021 EAN/PNS CIDP Guidelines and the 2023 GBS Guidelines. His interests have involved clinical aspects of Myasthenia Gravis, ALS and Charcot-Marie-Tooth Disease as well as the immune mediated neuropathies. His publications have also emphasized the electrodiagnostic and clinical aspects of inherited and acquired demyelinating neuropathy.  Dr. Lewis is known for his discovery and exploration Multifocal Demyelinating Neuropathy, which has been called the Lewis-Sumner syndrome, a variant of CIDP. His current research endeavours relate to developing new treatments for immune mediated neuropathies.

Jeremy Shefner

Jeremy Shefner, MD, PhD
Common Spirit Health

Jeremy Shefner, MD, PhD, is Professor of Neurology at the Barrow Neurological Institute. He earned his medical degree from Northwestern University Medical School and his doctorate in sensory physiology from the University of Illinois. He completed his residency at Harvard Longwood Neurology Training Program and his fellowship in clinical neurophysiology at Brigham and Women’s Hospital.  Dr. Shefner is co-founder and former co-chair of the Northeast ALS (NEALS) Clinical Trials Consortium, the largest ALS-dedicated group of its kind in the world. He continues to direct NEALS outcomes and clinical monitoring cores, currently involved in multiple clinical trials. His main research focus is the development of novel outcome measures for ALS trials. 

Dr. Shefner has published more than 250 chapters and papers in peer- reviewed journals and has served on multiple grant review panels. In 2014, Dr. Shefner received the Sheila Essey Award for ALS Research, the major award given annually by the ALS Association and the American Academy of Neurology. He was awarded the Sean M. Healey International Innovation Prize for ALS in 2022, and in 2023 received the Forbes Norris Award for ALS given by the International Alliance of ALSMND Associations.